Ion channels represent a large but under-exploited class of drug targets beyond G protein-coupled proteins (GPCRs)
Collaboration combines Sosei Heptares' leading structure-based drug design platform with Metrion Biosciences' ion channel expertise
Joint drug discovery program to focus on a single ion channel that is a well-validated target for neurological diseases
PR Newswire
TOKYO and CAMBRIDGE, England, Feb. 1, 2021